Diabetes Pode Ser Curado Review and Ads Breakdown

What Is Diabetes Pode Ser Curado

Diabetes Pode Ser Curado appears to be a diabetes-focused VSL offer built around the idea that type 2 diabetes can be addressed through AMPK activation. The transcript does not clearly disclose whether the final offer is a supplement bottle, a protocol, a guide, a membership, or a bundled package. It does, however, discuss two specific components: berberine and chromium picolinate.

The name translates roughly from Portuguese as “Diabetes Can Be Cured.” That wording is extremely aggressive from an editorial and compliance standpoint. The transcript itself also uses language like “treatment,” “cure,” “escape route,” and “turns your diabetes on and off.” In this review, those are treated as claims made by the presentation, not medical facts. Type 2 diabetes is a serious condition, and the provided transcript does not prove that this product cures, treats, or reverses diabetes.

The VSL’s central character is Dr. Andrew Stewart. He introduces himself as a scientist, physician, professor at the University of Utah, and holder of a PhD from Southern Illinois University. He claims that his team were pioneers in AMPK protein research and that AMPK is “the very key” that turns diabetes on and off. That statement is the main authority anchor for the pitch.

The offer is framed as something viewers can “start doing at home today.” But the provided transcript ends before a full commercial offer is revealed. There is no price, no dosage, no refund policy, no bottle count, no supplement facts panel, and no safety guidance. That missing information is important. A persuasive VSL can make a mechanism feel clear, but a buyer still needs the actual product details before making an informed decision.

In practical terms, Diabetes Pode Ser Curado is best understood as an AMPK diabetes supplement pitch or blood sugar support protocol pitch. It does not read like a neutral diabetes education video. It is a tightly engineered direct-response presentation designed to make viewers dissatisfied with conventional treatment and curious about a natural AMPK-based alternative.

The Problem It Targets

The VSL targets more than high blood sugar. It targets the emotional and physical burden of type 2 diabetes: exhaustion, hunger, guilt, fear, dependency, and distrust.

According to the presentation, the conventional view focuses too much on excess sugar in the blood. The speaker says that blood sugar is “the smoke,” not “the fire.” The fire, in his framing, is that cells are “literally starving to death.” This phrase, cellular starvation, is the emotional and scientific center of the pitch.

The script describes the target viewer as someone who wakes up tired, feels hungry all the time, struggles with cravings, and feels blamed for their condition. The speaker says the person is not lazy and not guilty. They are described as a victim of a cellular energy problem. This is powerful copy because it relieves shame while creating a new cause to believe in.

The transcript also names the feared complications of diabetes in vivid terms. It mentions blurry vision, cloudy vision, nerve damage, tingling, numbness, sharp shooting pains, kidney failure, heart attacks, strokes, and amputation. The opening emotional hook about a mother losing her feet makes the later complication list feel personal rather than abstract.

The pain point is not merely, “My blood sugar is high.” The real pain point is, “I am doing what I was told, but I still feel worse.” The VSL repeatedly returns to that idea. The speaker describes patients whose lab reports improved while their lives deteriorated. He says they became more tired, heavier, and more hopeless. That is the emotional gap the offer tries to fill.

The VSL also targets frustration with metformin. According to the presentation, metformin creates the “illusion of control” by making the blood test look better while failing to fix the locked-cell problem. The speaker claims users eventually need higher doses and may experience fatigue, digestive issues, gas, stomach pain, diarrhea, and metallic taste. These statements are part of the VSL’s argument; they should not be used as a reason to stop or change medication without medical supervision.

How Diabetes Pode Ser Curado Works

The mechanism presented for Diabetes Pode Ser Curado is built around a hotel analogy. Blood vessels are described as hallways. Glucose is described as guests moving through the hallways. Cells are the rooms. Insulin is the force that pushes glucose toward the room. But, according to the speaker, insulin cannot complete the job unless the door opens.

That door-opening element is identified as AMPK protein.

In the VSL’s explanation, type 2 diabetes is framed as a condition where insulin resistance prevents glucose from entering cells efficiently. The speaker says glucose remains in the bloodstream, creating toxic buildup, while the cells remain hungry. This is why, according to the presentation, a person can have too much sugar in the blood and still feel drained, hungry, and underpowered.

The claimed solution has two parts.

First, the presentation says berberine can wake up dormant AMPK. The speaker describes screening hundreds of natural compounds from plants, roots, and barks used in Eastern medicine. Most allegedly had little effect. Then the team tested a compound from a plant with golden bark, traditionally used in Asia for heart problems. According to the VSL, this compound made AMPK activity surge by over 700% in lab cells where AMPK had been inactive.

Second, the presentation says chromium picolinate supports insulin’s job. The speaker claims that in long-term diabetes, even after AMPK is awakened, insulin may be weakened by years of overload and inflammation. In the hotel metaphor, the door may be unlocked, but the messenger is too tired to push it open effectively. Chromium picolinate is introduced as the mineral form that helps optimize insulin function.

So the proposed Diabetes Pode Ser Curado model is not simply “lower blood sugar.” It is reactivate AMPK plus strengthen insulin efficiency. The VSL presents this as more complete than metformin because it claims to address the cellular-door problem rather than merely reducing glucose levels in the bloodstream.

However, the transcript does not provide the full supplement formulation. It does not show dosages. It does not identify the exact plant source, extraction method, standardization level, bioavailability technology, third-party testing, contraindications, or clinical validation for the finished product. Those are major missing details for any serious Diabetes Pode Ser Curado ingredients review.

Key Ingredients and Components

The transcript names only two specific components: berberine and chromium picolinate. It does not disclose a complete ingredient list.

Berberine is the star ingredient in the VSL. According to the presentation, the speaker’s team found a specific berberine compound from a golden-bark plant that caused AMPK activity to rise by over 700% in lab cells. The VSL uses this claim to position berberine as the “key” for the AMPK lock.

The presentation also includes an important market-warning angle. It says viewers should not simply search online and buy ordinary berberine because “the vast majority” of berberine sold on the market allegedly does not work for this purpose. The speaker claims most versions have low purity, inferior plant variety, and poor absorption. This is a common direct-response supplement tactic: name a known ingredient, then argue that only the offer’s version has the right source, purity, or bioavailability.

The second named component is chromium picolinate. According to the VSL, chromium is essential for insulin function, and chromium picolinate is the most bioavailable and effective form for this job. The script is careful to give chromium a different role from berberine. It says chromium does not activate AMPK. Instead, it strengthens insulin’s ability to transport glucose.

That distinction helps the pitch feel more scientific. Berberine is not asked to do everything. Chromium is not treated as redundant. The two are positioned as specialists in a coordinated system: berberine wakes AMPK, and chromium picolinate supports insulin efficiency.

Because the transcript does not provide a full label, any broader ingredient discussion must be framed carefully. Typical blood sugar support supplements may include nutrients such as cinnamon extract, alpha-lipoic acid, bitter melon, banaba leaf, magnesium, vanadium, gymnema, or other metabolic-support compounds. But none of those are confirmed in the provided Diabetes Pode Ser Curado VSL. The only ingredients actually named in the transcript are berberine and chromium picolinate.

The missing details matter. For berberine, informed buyers would want to know the dose per serving, source species, extract standardization, purity testing, heavy metal testing, and whether absorption enhancers are used. For chromium picolinate, they would want to know the microgram dose, daily serving directions, and whether the formula is appropriate for people already taking diabetes medication. The transcript provides none of that.

The VSL Hook and Story

The Diabetes Pode Ser Curado VSL opens with a testimonial-style emotional shock. A person says they are devastated and suggests that earlier access to the information might have prevented their mother’s amputation. This is not a gentle opening. It is designed to make viewers feel the cost of not knowing.

The next hook is the authority reveal. The speaker introduces himself as Dr. Andrew Stewart, a scientist, physician, professor, and PhD. He immediately claims that his team were pioneers in AMPK research. This establishes the frame: the viewer is not listening to a marketer, but to a medical insider who has supposedly discovered the missing mechanism.

Then the VSL introduces its biggest claim: suffering from type 2 diabetes symptoms is “optional” because an escape route has already been discovered. That line is provocative on purpose. It creates tension, even offense, so the audience asks for clarification. The speaker then softens it by saying people are not choosing to suffer; rather, the map has been hidden from them.

The story moves into personal regret. The speaker says he once followed the rules by prescribing metformin, recommending carb restriction, and advising exercise. He describes watching patients’ lab numbers improve while the patients themselves became more tired, heavier, and more defeated. This sets up conventional medicine as incomplete and emotionally unsatisfying.

The turning point is his move from clinic to lab. The speaker says he spent almost a decade looking for the real cause of type 2 diabetes. He then introduces cellular starvation and the AMPK door mechanism. This is the educational core of the VSL.

The midpoint is the villain escalation. Metformin is not merely described as incomplete. It is framed as sabotage. The speaker says it blocks glucose from food and suppresses glucose production by the liver, making blood sugar numbers look better while starving cells of energy. This is a highly adversarial portrayal and should be read as the VSL’s claim, not balanced medical guidance.

The second act becomes a legal thriller. The speaker says he posted a simple video criticizing metformin and Teva’s efficacy data, that the video reached millions, and that Teva sued him for $50 million. He says the lawsuit was meant to destroy him, but he won, and the jury awarded him $2 million for malicious prosecution. This story gives the pitch a “they tried to silence me” structure.

Finally, the VSL reveals the natural key: berberine, followed by chromium picolinate. This sequence is deliberate. The viewer must first feel afraid, betrayed, educated, and aligned with the doctor before the ingredient reveal arrives.

Ads Breakdown

The likely ad angles for Diabetes Pode Ser Curado are clear from the transcript. The VSL is packed with hooks that can be converted into short-form ads, advertorial headlines, native ads, and email subject lines.

The first ad angle is the amputation regret hook. The opening line about a mother losing both feet is built for interruption. It suggests that the viewer may be missing information that could prevent devastating outcomes. This angle would likely be aimed at people caring for diabetic parents or people afraid of diabetic complications.

The second angle is the doctor whistleblower hook. The speaker says he is a physician, scientist, professor, and AMPK researcher who fought a pharmaceutical giant. Ads could frame him as “the doctor Teva tried to silence” or “the professor who exposed the diabetes mistake.” This kind of hook is common in supplement funnels because it combines authority with rebellion.

The third angle is the metformin betrayal hook. The VSL claims metformin was designed to manage people, not cure them. It uses phrases like “perfect monthly subscription” and “your cure is their bankruptcy.” This angle targets viewers who already feel frustrated with medication, side effects, or dose increases.

The fourth angle is the cellular starvation hook. Rather than saying “lower blood sugar,” the pitch says the cells are starving while sugar remains trapped in the bloodstream. This is a strong mechanism hook because it explains fatigue, hunger, and cravings in one simple story.

The fifth angle is the AMPK switch hook. The transcript says AMPK is the key that turns diabetes on and off. That phrasing is highly clickable because it compresses a complex condition into one hidden biological switch.

The sixth angle is the 700% berberine hook. According to the speaker, the right berberine made AMPK activity surge by over 700% in lab cells. This is the closest thing in the transcript to a quantified science claim, and it is likely to be used heavily in ads.

The seventh angle is the ordinary berberine warning. The VSL tells viewers not to buy random berberine online because most of it allegedly has low purity and poor absorption. This protects the offer from commodity comparison. Instead of asking, “Why not buy cheaper berberine elsewhere?” the viewer is led to ask, “Which berberine is the right one?”

The eighth angle is the simple analogy hook. The hotel hallway and locked-door explanation can be turned into visual ads, quizzes, and advertorials. It is easy to understand and emotionally satisfying because it makes the viewer’s symptoms feel logical.

Psychological Triggers and Persuasion Tactics

The strongest psychological trigger in Diabetes Pode Ser Curado is fear of loss. The VSL repeatedly mentions frightening outcomes: amputation, blindness, kidney failure, nerve pain, stroke, and heart attack. These are not presented as distant medical concepts. They are personalized through the opening story and through sensory details like tingling, numbness, needles, and cloudy vision.

The second major trigger is relief from blame. The viewer is told that their fatigue is not laziness and their hunger is not weakness. According to the presentation, the real issue is cellular starvation caused by glucose being locked out of cells. This is emotionally powerful because it offers dignity before offering a product.

The third trigger is anger at a villain. Teva, metformin, and the pharmaceutical business model are framed as forces that profit from management rather than resolution. The line “your cure is their bankruptcy” is one of the most aggressive persuasion moments in the transcript. It turns buying into an act of resistance.

The fourth trigger is authority. Dr. Stewart’s claimed credentials are repeated early: scientist, physician, professor, PhD, AMPK pioneer. The courtroom story adds moral authority, suggesting he risked his career and home to tell the truth.

The fifth trigger is cognitive fluency. The hotel analogy makes the mechanism feel obvious. Glucose in hallways, cells as rooms, insulin as the mover, AMPK as the door opener: once the viewer understands the metaphor, the proposed solution feels intuitive.

The sixth trigger is specificity. The VSL cites 150 million daily metformin users worldwide, a $50 million lawsuit, a 500-page legal document, a $2 million jury award, and a 700% AMPK activity surge. Specific numbers make a story feel more concrete, even when the transcript does not provide independent documentation.

The seventh trigger is scarcity of truth rather than scarcity of product. There is no countdown timer or limited inventory in the provided transcript. Instead, the scarcity is informational: the map was hidden, the industry suppressed it, and most doctors supposedly do not talk about AMPK.

The eighth trigger is mechanism exclusivity. The VSL does not merely say berberine works. It says most berberine does not work because of purity, origin, and absorption problems. That preserves uniqueness even when the ingredient itself is widely available.

Scientific and Authority Signals

The transcript uses several scientific and authority signals, but they vary in strength.

The strongest internal authority signal is the speaker’s claimed identity: Dr. Andrew Stewart, scientist, physician, professor at the University of Utah, and PhD from Southern Illinois University. The VSL relies heavily on this profile. However, the provided transcript does not include independent verification, publication links, institutional pages, or study citations.

The second authority signal is AMPK. AMPK is a real biological concept, but this review is limited to the transcript. The presentation uses AMPK as the central mechanism behind glucose access to cells. It says AMPK is the door-opening protein and that dormant AMPK causes the diabetes cascade. That explanation is simplified for persuasion.

The third science signal is the alleged screening of hundreds of natural compounds. The speaker says his team tested extracts from plants, roots, and barks used in Eastern medicine. He claims most had little effect, while a golden-bark compound caused AMPK activity to surge by over 700%. The transcript does not identify the study design, cell type, dosage, compound standardization, publication venue, or whether this result translated to humans.

The fourth science signal is berberine. The VSL presents berberine as a natural AMPK activator. It also argues that the right purity and origin are essential. This lets the offer borrow familiarity from a known supplement category while still claiming differentiation.

The fifth science signal is chromium picolinate. The presentation positions it as the most bioavailable and effective form of chromium for insulin support. Again, no dose or product-specific clinical data is included in the transcript.

The sixth authority signal is the lawsuit story. Courtroom narratives can feel like proof because they imply public scrutiny. In this transcript, the lawsuit is used to validate the speaker’s courage and the threat his message supposedly posed to Teva. But the provided text does not include case numbers, court records, dates, or documents.

A research-first reader should separate three things: what the VSL claims, what the ingredients are generally associated with, and what is proven for this specific offer. Based on the provided transcript, the specific offer is not clinically proven. The script is persuasive, but it is not a substitute for medical evidence.

What Real Buyers Say

The provided transcript does not include conventional buyer testimonials with names, before-and-after data, star ratings, or verified purchases. It does include audience reactions and testimonial-style lines.

One person says, “Doctor, I'm just absolutely devastated by what I've just heard.” That line is designed to communicate shock and regret. Another says, “If I had known this 18 months ago, my mother would possibly still have both of her feet to walk on.” This is the strongest emotional proof line in the transcript, but it is not proof that Diabetes Pode Ser Curado prevented amputation.

Another audience voice says, “I've lost count of how many years I've been trying to get the same health results that your patient got in months.” This suggests there was a patient case shown before or during the lecture, but the provided transcript does not include that patient’s full story, medical records, timeline, or baseline numbers.

The transcript also includes the line, “Doctor, this is truly going to be the turning point in my life.” This is an intent statement, not an outcome testimonial. The person is expressing hope after hearing the presentation, not reporting verified results from using the product.

Other lines reinforce audience buy-in. Someone says, “The way you describe that, it's exactly what my mother says she feels every single day.” Another says, “What you've just told us is disturbing, to say the least.” These are useful for persuasion because they show the audience recognizing their own experience in the story.

The speaker himself claims that his “greatest success stories” are his patients and that hundreds of private patients have had transformed lives. He also says patients get better in ways most doctors call impossible and in a short amount of time. But the transcript does not provide 10 to 15 complete verified buyer testimonials. It does not give names, ages, A1C changes, medication changes, physician confirmations, or safety outcomes.

So the honest conclusion is this: the VSL uses testimonial-style language, but the provided transcript does not contain enough substantiated buyer proof to independently validate the product’s claims.

The Offer / Pricing / Risk Reversal

The provided transcript does not disclose the commercial offer. There is no stated price for Diabetes Pode Ser Curado. There is no mention of one bottle, three bottles, six bottles, subscription billing, shipping, taxes, checkout terms, or refund period.

There are also no bonuses mentioned in the provided text. Many supplement VSLs eventually add bonuses such as digital guides, meal plans, detox protocols, or quick-start reports, but none are present in this transcript. We cannot assume they exist.

The transcript also does not mention a guarantee. There is no “60-day money-back guarantee,” no “180-day risk-free trial,” and no refund instructions in the provided text. That is a significant gap because risk reversal is often central to VSL conversion.

Instead of price anchoring against a product cost, the VSL anchors against the cost of conventional diabetes management. It talks about metformin dependency, rising dosages, pharmaceutical profits, Teva’s alleged $17 billion revenue, and a lifetime of managed symptoms. The implied argument is that the hidden AMPK approach is more valuable than staying trapped in the conventional model.

The biggest risk-reversal element is narrative rather than contractual. The speaker says the lecture was funded by the $2 million he allegedly won from Teva and that he promised not to use the money for personal benefit. That makes the message feel mission-driven. But it is not the same as a buyer guarantee.

Before purchasing any offer like this, a cautious buyer would need the full Supplement Facts panel, dosing instructions, contraindications, medical disclaimers, refund policy, total checkout cost, and subscription terms. Those are not available in the provided transcript.

Who This Is For (and Who It Isn't)

Based on the VSL, Diabetes Pode Ser Curado is aimed at adults concerned about type 2 diabetes, especially those who feel conventional advice has not helped them feel better. It is written for people who identify with fatigue, hunger, cravings, and frustration despite trying to follow medical guidance.

It is also aimed at caregivers. The opening line about a mother’s amputation makes the offer emotionally relevant to sons, daughters, spouses, and family members worried about diabetic complications. The transcript repeatedly says the audience either has type 2 diabetes or loves someone who does.

The offer may appeal to people who are interested in natural blood sugar support, AMPK activation, berberine, and chromium picolinate. It may also appeal to people who distrust pharmaceutical companies or feel that the medical system focuses too much on lab numbers and not enough on quality of life.

However, this is not for people looking for a fully documented clinical presentation. The transcript does not provide citations, product studies, dosage details, safety data, or independent verification. Anyone who needs hard evidence before considering a supplement will find major gaps.

It is also not for anyone who might interpret the VSL as permission to stop medication. The presentation is highly critical of metformin, but diabetes medication decisions should be made with a qualified medical professional. Stopping or changing diabetes medication without supervision can be dangerous.

It is not appropriate to treat this transcript as proof of a cure. The product name and VSL language may imply dramatic outcomes, but the provided material does not prove that Diabetes Pode Ser Curado cures diabetes, reverses diabetes, prevents amputation, or eliminates the need for medical care.

Frequently Asked Questions

What is Diabetes Pode Ser Curado?

Diabetes Pode Ser Curado is presented in the transcript as a diabetes-focused VSL offer centered on AMPK activation and insulin support. The exact product format is not fully disclosed in the provided text.

What ingredients are mentioned in the Diabetes Pode Ser Curado VSL?

The transcript specifically names berberine and chromium picolinate. According to the presentation, berberine wakes up AMPK, while chromium picolinate supports insulin efficiency.

Does Diabetes Pode Ser Curado prove it can cure diabetes?

No. The transcript makes strong claims, but it does not provide product-specific clinical trials, full study citations, dosage information, or independent verification. The claims should be treated as claims from the presentation.

What does AMPK mean in the VSL?

According to the VSL, AMPK is the protein that opens the cellular door so glucose can enter cells and become energy. The presentation claims dormant AMPK is the hidden cause behind cellular starvation.

Does the VSL disclose the price?

No. The provided transcript does not mention the price, bottle count, discount, subscription terms, shipping cost, or refund policy.

What does the presentation say about metformin?

The VSL claims metformin manages blood sugar numbers without fixing the underlying cellular-door problem. It also frames metformin as part of a pharmaceutical business model. This is the speaker’s argument and should not be treated as medical advice.

Who is Dr. Andrew Stewart?

The transcript identifies him as a scientist, physician, professor at the University of Utah, and PhD from Southern Illinois University. The presentation uses him as the central authority figure, but the transcript does not provide independent documentation.

Should people with diabetes use Diabetes Pode Ser Curado?

Anyone with diabetes should consult a qualified healthcare professional before using supplements or changing medication. The transcript alone does not provide enough safety or efficacy information to make a medical decision.

Final Take

Diabetes Pode Ser Curado is a highly emotional, mechanism-heavy diabetes VSL built around one central idea: type 2 diabetes symptoms come from cellular starvation caused by dormant AMPK, and the right combination of berberine and chromium picolinate can address that mechanism. The presentation is memorable because it combines a simple analogy, a credentialed doctor figure, a pharmaceutical villain, a courtroom story, and a natural-compound discovery.

From a direct-response perspective, the VSL is strong. It has a dramatic opening, a clear enemy, a vivid mechanism, high-stakes consequences, scientific language, and a differentiated ingredient angle. The AMPK switch, 700% berberine claim, and metformin betrayal story are all built for ads and advertorials.

From an editorial research perspective, the gaps are just as important. The transcript does not provide a full ingredient label, dosage, price, guarantee, clinical trial citation, product-specific evidence, or verified buyer results. It also makes aggressive claims about diabetes and metformin that require medical caution.

The most grounded conclusion is this: Diabetes Pode Ser Curado is a persuasive AMPK diabetes supplement VSL, not proven medical evidence. The transcript gives us the pitch, the mechanism, and the named ingredients. It does not give us enough to verify the product’s safety, efficacy, or value.

For readers studying the offer, the key question is not whether the story is compelling. It is whether the final product, label, evidence, and terms can support the weight of the claims made in the VSL.

Disclaimer: This article is for research and educational purposes only. It is not medical, legal, or financial advice, and it is not affiliated with the product or its makers. Always consult a qualified professional before making health or financial decisions.